NCT04419233 - Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

November 21, 2023

Study Completion Date

November 21, 2023

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG

Nusinersen Sodium Injection

Administered as specified in the treatment arm.

Trial Locations (9)

Research Site, Xicheng

Research Site, Beijing

Research Site, Changchun

Research Site, Minhang

Research Site, Hangzhou

Research Site, Chengdu

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Suzhou